Login or Register to make a submission.

Submission Preparation Checklist

As part of the submission process, authors are required to check off their submission's compliance with all of the following items, and submissions may be returned to authors that do not adhere to these guidelines.
  • 1. Manuscript Preparation:
    The author(s) affirm that the material has not been previously published and that the author(s) have not transferred elsewhere any rights to the article. The author(s) have checked the manuscript to comply with the instructions for authors of Indonesian Journal of Kidney and Hypertension.
  • 2. Informed Consent:
    The author(s) haven’t suggested any personal information that may make the identity of the patient recognizable in any forms of description part, photograph or pedigree. When the photographs of the patient were essential and indispensable as scientific information, the author(s) have received the consent in writing form and have clearly stated it.
  • 3. Human & Animal Right:
    In case of experimenting on human, the author(s) have certified that the process of the research is in accordance with ethical standards of Helsinki declaration, domestic and foreign committees that preside over human experiment. If any doubts is raised whether the research was proceeded in accordance with the declaration, the author(s) would explain it. In case of experimenting on animals, the author(s) have certified that the author(s) had followed the domestic and foreign guideline related to experiment of animals in a laboratory.
  • 4. Permission approvals:
    The author(s) have received consent from the author or editor the picture or the table that was quoted from other journals or books. A portion or entire of the article other than the abstracts hasn’t been published on other journals nor contributed to other journals and under review.
  • 5. Copyright Notice:
    The author(s) undersigned hereby give Indonesian Society of Nephrology as publisher the right of first publication of all published material and licensed under a Creative Commons AttributionNonCommercial 4.0 International (http://creativecommons.org/licenses/by-nc/4.0/).
  • 6. Conflict of interest:
    Author(s) of the journal have clarified everything that interest may arise such as work, research expenses, consultant expenses, and intellectual property on the document of ICMJE form disclosure of conflicts of interest.

Author Guidelines

Indonesian Journal of Kidney and Hypertension (InaKidney) is an open access journal containing publications regarding kidney diseases and hypertension, reviewed and edited by reputable nephrologists in Indonesia and other countries.

No fee will be charged on authors; all expenses regarding publication are covered by Pernefri/InaSN. All the articles are free of charge for readers to download. All funds to operate the journal come from Perhimpunan Nefrologi Indonesia/Indonesian Society of Nephrology (Pernefri/InaSN).


Manuscript Preparation

  • A single word processing file, including title, authors, abstract, main text, references and figure legends.
  • Figure(s). Optional
  • Table(s). Optional


According to the World Association of Medical Editors, plagiarism is described as

“…the use of others' published and unpublished ideas or words (or other intellectual property) without attribution or permission, and presenting them as new and original rather than derived from an existing source. The intent and effect of plagiarism are to mislead the reader as to the contributions of the plagiarizer. This applies whether the ideas or words are taken from abstracts, research grant applications, Institutional Review Board applications, or unpublished or published manuscripts in any publication format (print or electronic).”

In order to prevent plagiarism, it is advised for authors to have their manuscripts screened for plagiarism using software such as iThenticate, before submission for publication. Any plagiarism detected before or after publication will be addressed promptly by the editorial board.

Ethical Issues in Experimental Study

Any experimental research with human and non-human subjects must include the mechanism of ethical approval and declaration of ethical approval by a local organization. 

Patient Consent and Privacy

Authors must state whether an informed consent both verbal and written, was obtained from every subject. Articles that must include identifiable features of patients such as pictures of the face, date of birth, etc. must be done in an appropriate manner.

Statement of Non-Duplication

All authors must certify that the manuscript submitted have never been published in other journals, nor is it being considered to be published in any other form of publication.

House Style

Any symbols, nomenclatures, and abbreviations must conform to the American Medical Association Manual of Style. The use of the international standard of units is advisable. A list of abbreviations must be included in the manuscript, following the title page.

Product Information

Medical products, devices, and material used in the study must be mentioned in full nonproprietary name, and if appropriate, its commercial name and manufacturer's name.


The qualification of authorship in InaKidney adheres to the International Committee of Medical Journal Editors (http://www.icmje.org/recommendations/browse/roles-and-responsibilities/defining-the-role-of-authors-and-contributors.html). Author name should be listed in First Name – Middle Name – Surname.

Reporting Guideline and Article Types

Each article submitted must be prepared according to guidelines and/or checklists based on its type, defined by the EQUATOR Network. https://www.equator-network.org/reporting-guidelines/




Text should be 1.5-spaced. The typeface should be Times/Times New Roman or similar serif typeface. Body text size should be no smaller than 10 pt and no larger than 12 pt.  Page size should be international A4 size (210 × 297 millimeters). Include page numbers in the manuscript file.


The full title should be specific, descriptive, concise, and comprehensible to readers outside the subject field. Authors should include the species or model system used (for biological papers) or the type of study design (for clinical papers).

Authors and Affiliation

 All author names should be listed in the following order: First names, middle names (or initials, if used), and last names (surname, family name), followed by medical and/or highest academic degrees (eg, MD, Ph.D.). Each author should list an associated department, university, or organizational affiliation and its location, including city, state/province (if applicable), and country. Other parties who contributed to the scientific paper that did not meet the criteria for authorship can be listed in the Acknowledgement section.

When a large group or center has conducted the work, the author list should include the individuals whose contributions meet the authorship criteria defined above, as well as the group name. Authors should also disclose whether they had any writing assistance.

One author should be designated as the corresponding author, and his or her email address should be included on the manuscript cover page. This information will be published with the article when accepted.


The abstract should be no more than 350 words, summarizing the problem being considered, how the study was performed, the salient results, and the principal conclusions. Specific instructions regarding abstract structure are often included in the relevant reporting guidelines checklist.

Introduction/Materials and Methods/Results/Discussion and Conclusions

The overall structure of your manuscript text should be in compliance with the corresponding reporting guideline. For example, a CONSORT compliant manuscript should include the following sections, as defined by the CONSORT checklist:

  • Introduction
  • Methods
  • Results
  • Discussion
  • Other Information

Statistical Analysis

In the Methods section:

  • Identify the statistical tests used to analyze the data and the determined P value that was taken to indicate a significant difference.
  • Cite only textbooks and published article references to support your choices of tests.
  • Identify any statistics software used. (List software name, version, and company in parentheses in the text, not in the reference list.)

In the Results section:

  • Report actual P values rather than thresholds: not just whether the P value was above or below the significant-difference threshold. Example: write "P = 0.18", not "P > 0.05" or "P = NS."
  • P should be expressed to 2 digits for P ≥ 0.01 because expressing P to more than 3 digits does not add useful information. If P < 0.001, it should be expressed as P < 0.001, rather than P < 0.0001 or P = 0.00001 for example. In certain types of studies, it may be important to express P values to more significant digits. Please consult the AMA Manual of Style for further direction. 


Before submitting, please be sure that you have gathered the following requirements:

  • For all authors:

o          First and last name

o          Postal address

o          Email address

o          Work telephone number

o          Work fax number

o          Potential conflict of interest

  • Article title (can be copied and pasted from the manuscript)
  • Abstract (can be copy and pasted from the manuscript)
  • Covering letter (this will not be visible to the reviewers)
  • The manuscript file, which should include the main article and any tables and/or text boxes
  • Figure files; each figure should be saved as a separate file
  • Contact information (name, email address, and institution) of any peer-reviewers to be considered for contact or exclusion


Original Article

Original articles must have a maximum of 300 characters for structured abstracts and 3,500 characters for the article, excluding abstract, references, tables, and figure legends. The number of references should be no more than 50 and the number of figures, tables, and graphs should not exceed 8 in total.

Clinical Trial: an experimental study assessing the effect of 2 or more interventions. Reporting should follow the CONSORT flowchart matching the study design. For non-randomized trials involving habit or behavioral interventions, follow the TREND guidelines. 

Decision Analysis or Cost-Effectiveness Analysis: a study analyzing the optimal choice of clinical care by projecting the consequences of different medical care options. The report should follow the Second Panel on Cost-Effectiveness in Health and Medicine (Sanders et al. JAMA. 2016;316[10]: 1093-1103) to report economic evaluations of health interventions.

Diagnostic Study: A study that compares the performance of 2 or more diagnostic tests or strategies. Authors should follow the STARD guidelines.

Observational Study: Studies that observe patients who are exposed to certain potential risk factors or interventions, where researchers do not assign the interventions to the study’s subjects. This includes cohort, case-control, and cross-sectional studies. Authors should follow the STROBE guidelines with respect to their study designs.

Prognostic Study: A study that estimates the risk of a certain clinical endpoint associated with potential risk factors or predictors in a defined period of time. Authors should follow the TRIPOD guidelines.

Systematic Review or Meta-Analysis: A systematic review is an appraisal of current evidence in a certain field, using an explicit protocol to identify, appraise, and synthesize the studies of a similar question. Meta-analysis further quantifies the result of a systematic review. Authors should use the PRISMA flow diagram to report the study yield and selection.

Case Report

A case report presents an interesting, rare, and/or novel clinical case regarding newly described clinical presentation, diagnostic dilemma, or treatment responses that need further insight into the underlying mechanism. Limited to 1,500 words and requiring an unstructured abstract (150-200 words). The reference list should be no more of 20 in total and tables/figures should be a maximum of 2 in total. Authors should follow the CARE guidelines when applicable.

Evidence-Based Case Report: An evidence-based case report (EBCR) is a case report from which the author formulates a structured clinical question. This question generates key terms that can be used for yielding articles from an evidence database. After the relevant evidence has been identified and appraised, clinician informs a management plan for the patient based on the result and the clinician’s clinical experiential knowledge.

Review Article

Also known as a narrative review, this article explores clinical, translational, or basic science topic of interests. The article should be comprehensive, clinically relevant, and balanced. Basic science articles should discuss the relevance of cellular or biomolecular aspects to clinical diagnosis, prognosis, or treatment. The article should consist of up to 4000 words, including 150-200 words of unstructured abstract. The reference list should be no more than 100. Authors are encouraged to use figures, tables, and boxes up to 8 in total.


Privacy Statement

The names and email addresses entered in this journal site will be used exclusively for the stated purposes of this journal and will not be made available for any other purpose or to any other party.